Keyword: Vaccine

Immunology

Butantan Institute stops development of ButanVac

The COVID-19 vaccine candidate’s ability to generate immunity was inferior to the Pfizer vaccine

By

Immunology

Butantan vaccine candidate reduces the risk of severe dengue fever by 89%

The compound proved safe and prevented 67.3% of those immunized from developing symptoms of the disease

By

Public Health

Vaccination rate for children under two on the rise since 2022

Experts attribute recovery to measures implemented at a municipal level and by other spheres of government

By

Interview

2024 could become the year with the highest number of dengue cases

FAMERP virologist Maurício Nogueira discusses the characteristics of the current epidemic and the need for the health system to prepare for more patients

By

Nobel Prize

Eleven people received a Nobel Prize in 2023

Four were women, the same number as in 2018 and 2020, only lower than in 2009, when there were five winners

By

BIOLOGY

Yellow fever virus has been circulating uninterrupted in southern Brazil for seven years

The disease vector arrived in the country’s southeast two to three years earlier than previously thought

By

EPIDEMIOLOGY

Falls in uptake of the MMR vaccine occurred at different rates between 2006 and 2020

The declines were greater in poorer municipalities and more intense during the economic crisis and the beginning of the COVID-19 pandemic

By

PHARMACOLOGY

A potential vaccine against cocaine abuse

Vaccine stimulates the production of antibodies against cocaine in animal experiments

By

Immunology

Antibodies defeat yellow fever in animals

Rodents and monkeys given an infusion of the compounds were able to survive infection

By

COVID-19

Thai version of vaccine similar to ButanVac induces good immune response

In phase 1 trials involving 210 people, the low-cost formulation produced more neutralizing antibodies than the Pfizer / BioNTech vaccine

By

Oncology

Vaccine candidate designed to treat cancer caused by HPV

In experiments on rodents, vaccine formulations eliminated tumors and rid the animals of the disease for a long time

By

IMMUNOLOGY

Butantan’s dengue vaccine is 80% effective

The vaccine offered protection against two serotypes of the virus in the final phase of human trials

By

IMMUNOLOGY

Construction begins on Brazil’s new National Vaccine Center in Belo Horizonte

The institution will function as a link between basic immunobiological research and final products

By

OBITUARY

Defender of access to science

Biochemist Isaías Raw produced internationally relevant research, actively disseminated knowledge, and contributed to the production of vaccines and immunobiologicals

By

Public health

Number of unvaccinated children rises

Brazil was one of the countries most affected by falling childhood vaccination in 2021

By

INTERVIEW

Margareth Dalcolmo: Pandemic scars

The physician-researcher discusses the difficulties faced by health professionals dealing with Covid-19, the dramatic struggles of patients she attended, and the likelihood of an increase in tuberculosis cases in the coming years

By and

Health

Nasal COVID-19 vaccine

Research into intranasal vaccines against Covid-19 is advancing

By

Cover

A drop in childhood vaccination

The pandemic has exacerbated a decline in immunization rates, which fell by 65% in some states in 2020

By

COVID-19

Another step towards a universal vaccine

Clinical trials begin for broad-spectrum vaccines designed to offer protection against multiple coronaviruses

By

COVID-19

Third dose lowers risk of death

Coronavirus vaccine booster doses significantly reduce the risk of death from COVID-19

By

GOOD PRACTICES

Preliminary study disseminated by anti-vaccine groups

Preliminary study disseminated by anti-vaccine groups

By

COVID-19

The quest for a Brazilian vaccine

Researchers are testing a range of technologies, but few initiatives will receive the funding needed for costly phase 3 clinical trials

By

Covid-19

Vaccines generate more consistent immune response

The immune response to the novel coronavirus provided by vaccines is more consistent than that triggered by natural infection with SARS-CoV-2

By

COVID-19

Two vaccines safe for children

The CoronaVac vaccine, produced in Brazil by the Butantan Institute, is safe for children and adolescents, with no major side effects

By

HEALTH

Pioneering immunization

Malaria vaccine recommended for children in Africa by the WHO is the first to protect humans from a parasite

By

Covid-19

Confidence in vaccines

Vaccination rate in Brazil greater than in developed countries

By

COVID-19

Vaccination in decline

The COVID-19 vaccination pace has been decreasing worldwide

By

COVID-19

First DNA-based vaccine

India has developed and approved the first COVID-19 vaccine based on DNA technology

By

COVID-19

Still too soon for booster doses

An international group of scientists argued against the idea of giving the majority of the population COVID-19 vaccine booster doses

By

Covid-19

Pfizer vaccine to be made in Brazil

Pfizer vaccine to be made in Brazil

By